- Barriers to HPV vaccine uptake extend beyond the most common factor: parent refusal.
- Other factors that pediatricians and nurse practitioners cite include insufficient time to explain the vaccine and less regular health care contacts for adolescents.
Why this matters
- Despite availability of the cancer-preventing vaccine since 2006, uptake remains remarkably low, in part because of parental concerns.
- This study suggests other openings for improvement.
- 100% of respondents cited more than a single barrier to uptake.
- Parent refusal/delay was most common (>80%).
- But 17% of clinicians also cited not having the time required to explain the vaccine sufficiently.
- 13% cited relatively few adolescents presenting for well visits.
- 11% cited not having enough training to provide a strong recommendation.
- 7% had difficulty administering the vaccine at an acute/chronic care visit.
- Most (89%) relied on prompts as a strategy to improve vaccination uptake.
- Only 17% used reminder calls.
- Survey data from pediatricians and nurse practitioners in 19 states, part of an American Academy of Pediatrics network.
- Funding: NIH.
- Self-report data presented at a conference without peer review.